Skip to main content
Bruce Giantonio, MD, Oncology, Philadelphia, PA

BruceJGiantonioMD

Oncology Philadelphia, PA

Associate Professor, Medicine, Perelman School of Medicine

Dr. Giantonio is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Giantonio's full profile

Already have an account?

  • Office

    3400 Spruce St
    15 Penn Tower
    Philadelphia, PA 19104
    Phone+1 215-662-3914

Education & Training

  • Temple University Hospital-Fox Chase Cancer Center
    Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 1990 - 1993
  • University of Vermont Medical Center
    University of Vermont Medical CenterResidency, Internal Medicine, 1987 - 1990
  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 1987

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2017 - 2026
  • NH State Medical License
    NH State Medical License 2024 - 2024
  • ME State Medical License
    ME State Medical License 2020 - 2021
  • PA State Medical License
    PA State Medical License 1990 - 2021
  • VT State Medical License
    VT State Medical License 1987 - 1990
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • A New Look at the International Duration Evaluation of Adjuvant Therapy (IDEA) Classification—Defining Novel Predictive and Prognostic Markers in Stage III Colon CancerMay 2018
  • A New Look at the International Duration Evaluation of Adjuvant Therapy (IDEA) Classification—Defining Novel Predictive and Prognostic Markers in Stage III Colon CancerMay 2018
  • A New Look at the International Duration Evaluation of Adjuvant Therapy (IDEA) Classification—Defining Novel Predictive and Prognostic Markers in Stage III Colon CancerMay 2018

Press Mentions

  • Donegal Woman Finally Starts Lifesaving Cancer Treatment in US
    Donegal Woman Finally Starts Lifesaving Cancer Treatment in USAugust 18th, 2021
  • Racial Disparities in Colon Cancer Survival Persist
    Racial Disparities in Colon Cancer Survival PersistDecember 30th, 2018